Sort   by:  
 Page size 
UnknownFine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Not available
S-EPMC4963094 | biostudies-literature
UnknownLarge-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
Not available
S-EPMC10942532 | biostudies-literature
UnknownGenome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.
Not available
S-EPMC12635163 | biostudies-literature
UnknownAssessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
Not available
S-EPMC4382299 | biostudies-literature
UnknownCorrection: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Not available
S-EPMC9090804 | biostudies-literature
UnknownMutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Not available
S-EPMC5903938 | biostudies-literature
UnknownGenome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.
Not available
S-EPMC6465407 | biostudies-literature
UnknownTranscriptome-wide association study of breast cancer risk by estrogen-receptor status.
Not available
S-EPMC7987299 | biostudies-literature
UnknownA case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Not available
S-EPMC7890067 | biostudies-literature
UnknownNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Not available
S-EPMC4630206 | biostudies-literature
Sort   by:  
 Page size